The Administration is hinting about being open to rescheduling – the betting markets aren’t Despite campaign promises, the current administration has made zero movement on cannabis rescheduling or any relief.  Leaders have even been known to say progress needs to be repealed, so they industry crossed their fingers and are holding their breath. But what are the odds of cannabis rescheduling?

As Washington plays its long game on cannabis policy, anyone trying to place a bet — literal or figurative — needs to understand the levers which move markets. Rescheduling marijuana from Schedule I to III (or descheduling it altogether) is no single act of presidential will: it’s a legal, scientific and political sieve. Here are the key factors driving the “odds” markets and pundits watch. First, the administrative roadmap matters. The Biden administration asked HHS and the Attorney General to review marijuana’s classification; HHS recommended moving cannabis to Schedule III and the DOJ/DEA issued a formal notice of proposed rulemaking — steps which create a legal timetable and public record investors and bettors can price in. Second, scientific and regulatory endorsements carry weight. HHS and FDA evaluations find “accepted medical use” or manageable public health risks make it easier legally to reclassify a drug — and they reduce political risk for a President who wants to claim an evidence-based approach. Administrative backing is why many analysts view rescheduling as procedurally plausible even if politically fraught. Third, the politics — both partisan and populist — shape the tail risk. Congressional pushback, pro- and anti-legalization lobbying, and changing agency leadership can slow or stall rescheduling even after agencies finish technical work. Recent reporting shows a robust anti-legalization counter-movement and procedural hurdles in agency hearings could delay outcomes. Those dynamics widen the odds range and lengthen timelines. Fourth, the legal process itself is a drag on quick outcomes. Rule-making, notice-and-comment periods, administrative hearings and possible judicial review create long windows where new information — court decisions, staffing changes, election results — can swing markets. Prediction markets typically discount long, legally complex outcomes because the information flow is slow and lumpy. Polymarket, one of the fastest-growing decentralized prediction markets, thrives on politically charged, binary-outcome questions — from election results to Supreme Court decisions. Cannabis rescheduling fits the bill: a concrete policy decision with a clear yes/no resolution and a definable deadline. Once the DEA sets a final action date, expect a market to open where traders can wager on whether rescheduling happens before the deadline. The volatility of political and legal developments would make it one of the more active contracts, with odds shifting on every new filing, leak, or press statement. Finally, public opinion and electoral calculation matter. Broad public support for legalization gives political cover, especially when the change can be framed as criminal-justice reform or pro-small-business tax relief. But close or contentious state votes, and targeted anti-reform campaigns, can make lawmakers and presidents more cautious — and that caution is reflected in slimmer betting odds. What this means for would-be bettors: look for administrative milestones (HHS/FDA reports, Federal Register notices, DEA hearings) as the most reliable catalysts shifting probabilities. Prediction markets and bookies will move when those documents or hearing outcomes arrive — until then, odds will reflect process risk as much as policy intent.

The Fresh Toast is a daily lifestyle platform with a side of cannabis. For more information, visit www.thefreshtoast.com.

The Fresh Toast